---
title: uBriGene vs VIRSCIO
slug_a: ubrigene
slug_b: virscio
site: cro
review_signal_gate: closed
canonical_path: /compare/ubrigene/virscio
---

# uBriGene vs VIRSCIO

Side-by-side profile data from each company listing on this directory.

## uBriGene

- Profile: [/companies/ubrigene](/companies/ubrigene)

uBriGene — uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. The strongest documented coverage currently appears in services (5).

### Services

- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- China NMPA Regulatory Strategy
- Analytical Method Development & Validation
- Translational Research

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## VIRSCIO

- Profile: [/companies/virscio](/companies/virscio)

VIRSCIO — Virscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.

Services: 8. Modalities: 3. Indications: 4. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Specialized & Large-Animal Models
- Clinical Imaging Core Lab
- Regulatory Affairs
- Translational Research
- Pathology & Histology Services

### Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Indications

- Neurology
- Metabolic
- Cardiovascular
- Ophthalmology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.